What Jiangsu Mole Bioscience Co. does

Jiangsu Mole Bioscience Co., Ltd. (江苏默乐生物科技股份有限公司) is a Chinese in vitro diagnostics (IVD) manufacturer founded in May 2008 and headquartered at the China Medical City (中国医药城) biomedical industrial park in Taizhou, Jiangsu Province, with a research and development base in Hangzhou tied to a Provincial Graduate Workstation jointly run with Zhejiang University. The company's core technical platform is multiplex fluorescent quantitative PCR (real-time PCR), supplemented by high-throughput sequencing and antigen-antibody immunoassay capabilities; on top of this platform it has built a portfolio of more than 200 registered reagent products and over 300 non-registered products spanning infectious disease (respiratory pathogens, HPV, enteric viruses, hepatitis, STI), tumor personalized medicine (K-ras, B-raf mutation kits), and drug-resistance mutation detection (H. pylori 23S rRNA/gyrA, Mycoplasma pneumoniae 23S rRNA). The firm also sells automated nucleic acid extraction instruments (Mole Fast96, Mole 32M/96M, MLN32/96, Mole 96H, MS8 workstation) and sampling consumables, giving it an integrated reagent-plus-instrument workflow for hospital and public-health laboratories.

The company derives revenue primarily from one-time sales of Class II and Class III registered IVD reagents and from hardware sales of extraction instruments and consumables to provincial and municipal key hospitals, CDC (Center for Disease Control) centers, and third-party inspection laboratories across China through a direct enterprise field-sales motion. Its go-to-market combines domestic direct sales with international distribution to more than 50 countries (export channel supplemented by participation in MEDLAB Dubai, MEDICA Germany, and AACC USA), and brand-building through academic symposia sponsorship (e.g., Nanjing Drum Tower Digestive Forum, West Lake Pediatric Respiratory Forum) and KOL relationships. Disclosed 2020 revenue exceeded CNY 300 million (approximately USD 42 million); the company is listed on China's National Equities Exchange and Quotations (NEEQ/New Third Board) under ticker 839185 and is currently in IPO coaching with Minsong Securities toward a mainboard listing.

Name

Jiangsu Mole Bioscience Co.

Legal name

江苏默乐生物科技股份有限公司

Website

https://molechina.com

Company type

Public

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Jiangsu Mole Bioscience is a Taizhou, China-based IVD manufacturer developing multiplex fluorescent PCR molecular diagnostic reagents, automated nucleic acid extraction instruments, and sampling consumables for hospitals, CDC centers, and third-party labs in China and 50+ international markets.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)

Keywords

• Molecular diagnostic reagents
• In vitro diagnostics
• PCR test kits
• Nucleic acid extraction
• Drug resistance testing

Headquarters

HQ city

Taizhou

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostic Reagent Sales: Sale of registered in vitro diagnostic reagents across infectious disease, tumor personalized medicine, and genetic testing categories. Revenue from both Class II and Class III medical device registration products. Includes 69 registered products and 300+ non-registered products.
2. Nucleic Acid Extraction Instruments and Equipment Sales: Sale of automated nucleic acid extraction instruments (Mole Fast96, Mole 32M, Mole 96M, MLN32, MLN96, Mole 96H, MS8 workstations), air samplers, and environmental pathogen monitors
3. Sampling Consumables: Sale of sampling kits including swab sampling sets, virus sampling tube sets (inactivated, culture, universal, pooled 10-in-1/5-in-1), and sample release agents
4. International Export Revenue: Products exported to more than 50 countries and regions globally

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Jiangsu Mole Bioscience Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular disease detection, leveraging multiplex fluorescent PCR technology. Its portfolio spans drug resistance detection kits (H. pylori, Mycoplasma pneumoniae), infectious disease panels, tumor personalized medicine tests, automated nucleic acid extraction instruments, and sampling consumables. The company sells Class II/III medical device-registered products through direct B2B channels to hospitals, CDC centers, and third-party testing laboratories in China and 50+ international markets.

Product overview

Jiangsu Mole Bioscience Co. (江苏默乐生物科技股份有限公司) is a high-tech enterprise established in 2008, specializing in molecular in vitro diagnostic reagents. The company offers a comprehensive portfolio centered on fluorescent PCR technology, including resistance testing kits (such as H. pylori and Mycoplasma pneumoniae resistance mutation detection), molecular reagent series for various disease categories (respiratory pathogens, intestinal viruses, hepatitis, tumors, sexually transmitted diseases), and automated nucleic acid extraction instruments (Mole Fast96, Mole 32M/96M, MLN32/96, Mole 96H, MS8 workstation). The product portfolio also includes sampling kits and environmental pathogen monitoring instruments. The company holds 69 medical device registration certificates with 18 Class III certificates and over 200 registered products, applying multiplex fluorescent PCR technology as the core platform.

Differentiator

Problem solved

Functional benefit

Products and services

• H. pylori 23S rRNA and gyrA Gene Mutation Detection Kit (Fluorescent PCR Method) Detects Helicobacter pylori 23S rRNA and gyrA gene mutations associated with clarithromycin and quinolone resistance, enabling clinicians to guide antibiotic therapy and prevent antibiotic misuse.
• Mycoplasma Pneumoniae Nucleic Acid and Resistance Mutation Site Detection Kit (Fluorescent PCR) Simultaneously detects Mycoplasma pneumoniae nucleic acid and macrolide resistance mutations to support early diagnosis and targeted treatment of Mycoplasma pneumoniae infections.
• Coronavirus (2019-nCoV) ORF1ab, E and N Gene Detection Kit (Fluorescent PCR Method) One-tube triple detection kit simultaneously detecting SARS-CoV-2 ORF1ab, E and N genes using fluorescent PCR technology for COVID-19 diagnosis.
• HPV Nucleic Acid Detection Kit (24-type Multiplex Fluorescent PCR) Multiplex fluorescent PCR kit detecting 24 HPV types including 18 high-risk types with competitive internal standard design, processing 94 samples in 90 minutes with 99.51% sensitivity.
• Mpox (Monkeypox) Virus PCR Detection Kit PCR detection reagent for mpox (monkeypox) virus, processing up to 94 samples in 70 minutes for rapid diagnosis of mpox infection.
• Respiratory Pathogen Detection Series Molecular diagnostic reagent series for detecting respiratory pathogens including influenza and other respiratory viruses, used by clinical laboratories.
• Tumor Detection Series (K-ras, B-raf Mutation Detection) Tumor individualization testing products including K-ras and B-raf gene mutation detection kits for personalized cancer treatment guidance in lung, colorectal, and papillary thyroid carcinoma.
• Intestinal Virus Detection Series Molecular diagnostic reagents for detecting enteric viruses including Enterovirus EV71, EV71/CA16, and universal enterovirus detection kits.
• Hepatitis Virus Detection Series Molecular diagnostic reagents for hepatitis virus detection used by clinical laboratories and hospitals.
• Sexually Transmitted Disease Detection Series Molecular diagnostic reagents for detecting sexually transmitted infections.
• Mole Fast96 Nucleic Acid Extractor 96-channel fully automatic nucleic acid extraction instrument for high-throughput sample processing in molecular diagnostic workflows.
• Mole 32M Fully Automatic Nucleic Acid Extractor 32-channel fully automatic nucleic acid extraction instrument for medium-throughput laboratory sample processing.
• Mole 96M Fully Automatic Nucleic Acid Extractor 96-channel fully automatic nucleic acid extraction instrument for high-throughput laboratory sample processing.
• MLN96 Fully Automatic Nucleic Acid Extractor 96-channel fully automatic nucleic acid extraction instrument for high-throughput laboratory sample processing.
• MLN32 Fully Automatic Nucleic Acid Extractor 32-channel fully automatic nucleic acid extraction instrument for laboratory sample processing.
• Mole 96H Automatic Nucleic Acid Extraction Workstation Automatic nucleic acid extraction workstation with integrated pipetting control, constant temperature oscillation module, and cold storage capabilities.
• MS8 Automatic Nucleic Acid Extraction and Separation Station Automatic nucleic acid extraction and separation workstation for laboratory automation.
• Nucleic Acid Extraction Reagents Reagents for nucleic acid extraction from various sample types, used with the company's automated extraction instruments.
• Sampling Kits Sampling kits including sampling swabs, inactivated virus sampling tubes, culture-type virus sampling tubes, and sample release agents in various specifications.
• Mole Air Biological Sampler Air sampling instrument with flow rate 100-300L/min, particle size >0.5μm, collection time 1-20 minutes per bottle, used for environmental pathogen monitoring.
• Environmental Sampler Environmental sampling device with 2-year validity, storage at 2-30°C, used for environmental monitoring applications.
• Environmental Pathogen Real-time Monitor Real-time monitoring instrument for environmental pathogens, used by public health and laboratory facilities for continuous environmental surveillance.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• 金域医学 (KingMed Diagnostics)coreStrategic or Co-development Partner · 9 December 2020Connected through Gold Summit Capital investment. KingMed Diagnostics is China's largest third-party medical testing laboratory network, providing laboratory management expertise and market channel access. Mole Bioscience's molecular diagnostics products can leverage KingMed's extensive testing network.
• 浙江大学 (Zhejiang University)coreStrategic or Co-development PartnerZhejiang University provides the talent and technology foundation for Mole Bioscience. The company collaborates with Zhejiang University on a Provincial Graduate Workstation (江苏省企业研究生工作站) approved by Jiangsu Provincial Department of Science and Technology and Education. The CTO Guo Xingzhong and R&D team are associated with Zhejiang University.

Scale indicators7 records

Recent moves10 records

Expansion highlights4 records

Broad incumbents

• Cepheid (Danaher): Global leader in molecular diagnostics with GeneXpert rapid PCR systems deployed across healthcare institutions worldwide. Sets the standard for integrated molecular diagnostic platforms that Mole Bioscience competes against in international markets.
• BGI Genomics: Largest Chinese genomics and molecular diagnostics company with PCR kits, NGS services, and COVID testing infrastructure. Significant overlap in infectious disease and oncology testing, with substantially greater scale and global brand.
• Snibe (Shenzhen New Industries Biomedical Engineering): Leading Chinese IVD manufacturer of chemiluminescence immunoassay systems with growing molecular diagnostics portfolio. Comparable Chinese hospital channel model with international expansion.
• Maccura Biotechnology: Sichuan-based Chinese IVD company offering clinical chemistry, immunoassay, and molecular diagnostic products. Comparable in serving Chinese hospitals with integrated instrument-reagent solutions.
• KingMed Diagnostics: China's largest third-party medical testing laboratory network and strategic partner of Mole Bioscience. Serves as both customer and channel partner; comparable in the broader molecular diagnostics ecosystem though operating a services model.
• Autobio Diagnostics: Major Chinese IVD company with broad portfolio in immunoassay, microbiology, and molecular diagnostics. Larger incumbent with comparable presence in Chinese hospital channels.
• bioMérieux: Global IVD company with broad molecular diagnostics, microbiology, and immunoassay portfolio. Comparable in serving clinical laboratories with integrated diagnostic solutions including drug resistance testing (e.g., VITEK systems).

Direct peers

• Sansure Biotech: Leading Chinese molecular diagnostics company offering fluorescent PCR/qPCR reagent kits for infectious diseases and HPV, with both domestic and international sales. Most direct comparable in product portfolio and Chinese hospital focus.
• Da An Gene (DaAn Genomics): Major Chinese IVD company offering PCR-based diagnostic kits across infectious disease, oncology, and genetic testing. Similar product portfolio with comparable Chinese hospital channel model.
• ZJ Bio-Tech (Liferiver): Shanghai-based molecular diagnostics company specializing in fluorescent PCR kits for infectious disease, oncology, and genetic testing. Similar mid-sized competitor targeting Chinese hospitals and international markets.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Jiangsu-Mole-Bioscience-Co-Ltd-100063767921911

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jiangsu Mole Bioscience Co.